Ensayos clínicos

ClinicalTrials.gov

Debajo puede consultar una lista con todos los ensayos clínicos abiertos en fase III sobre el cáncer, encontrades en el sitio web www.clinicaltrials.gov, que es un registro de ensayos clínicos de todo el mundo financiados tanto por gobiernos como por iniciativas privadas. Esta información es importada automáticamente de www.clinicaltrials.gov Siempre hable con su médico acerca de la posibilidad de participar en un ensayo clínico. Puede realizar su búsqueda en esta lista introduciendo un tipo de cáncer, un país concreto, una palabra clave o el código NCT del ensayo clínico de su interés. Si combina varias opciones obtendrá resultados más refinados. Por ejemplo, si usted es un paciente alemán de cáncer de mama, puede introducir en las cajas de búsqueda ‘cáncer de mama’ como tipo de cáncer y buscar los ensayos clínicos en Alemania. También puede buscar en diferentes lugares si está interesado en un determinado ensayo clínico en otros países. A partir del ensayo clínico elegido podrá acceder mediante un enlace a la página original de clinicaltrials.gov, que debe consultar para tener más información sobre el ensayo en cuestión. Cada semana la Fundación Contra El Cáncer selecciona nuevos ensayos clínicos disponibles para el cáncer. Esta sección del sitio web solo está disponible en inglés.
We hypothesize through this randomized, placebo-controlled adjuvant study, that Aspirin in patients with dukes C or high risk dukes B colorectal cancer (ASCOLT) can improve survival in this patient population over placebo control. If indeed found to be beneficial, because aspirin is cheap and easy to administer, it will positively impact the lives of many individuals in Asia and globally. STUDY OBJECTIVE To assess the effectiveness of Aspirin against...
<p>Patients with diagnosis of HPIN were enrolled. Patients were randomized into two groups: dutasteride treatment group and watchful waiting strategy group. According to the study protocol the subjects would undergo 10 core biopsies after 6, 12, 24, and 36 months after randomization. There are assessed the rate of prostate cancer at repeated transrectal ultrasound guided biopsies and the effect of 5 alfa reductase inhibitor (dutasteride) on prevention of prostate cancer development for...
<p>RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known which schedule of intensity-modulated radiation therapy is more effective in treating patients with prostate cancer. PURPOSE: This randomized phase III trial is studying the side effects of three schedules of intensity-modulated radiation therapy and compares how well they work in treating patients...
<p>RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. It is not yet known whether intensity-modulated radiation therapy is more effective than standard radiation therapy in treating patients with early-stage breast cancer. PURPOSE: This randomized phase III trial is comparing radiation therapy regimens in treating women with early-stage breast cancer who have undergone breast-...
RATIONALE: Screening may help doctors find colorectal cancer sooner, when it may be easier to treat. Finding out what affects a patient's decision to undergo screening tests may help increase the number of patients who undergo regular screening for cancer. It is not yet known whether personalized invitations to undergo colorectal cancer screening are more effective than standard screening reminders. PURPOSE: This randomized phase III trial is studying ways to...
Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as etoposide, carboplatin and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known which radiation therapy regimen is more effective when given together with chemotherapy in treating patients with limited-stage small cell lung cancer. This randomized phase III trial is...
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. PURPOSE: This randomized phase III trial is studying how well androgen deprivation therapy works in treating patients with prostate cancer.
RATIONALE: Wedge resection or segmentectomy may be less invasive types of surgery than lobectomy for non-small cell lung cancer and may have fewer side effects and improve recovery. It is not yet known whether wedge resection or segmentectomy are more effective than lobectomy in treating stage IA non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying different types of surgery to compare how well they work in treating patients with stage...
This randomized phase III trial studies whether changes in diet and physical activity can increase the length of survival without the return of cancer (progression-free survival) compared with usual care in patients with previously treated stage II, III, or IV ovarian, fallopian tube, or primary peritoneal cancer. A healthy diet and physical activity program and counseling may help patients make healthier lifestyle choices. It is not yet known whether changes in...